London School of Hygiene and Tropical Medicine

Academic Institute

Krishnan Bhaskaran - Chief Investigator - London School of Hygiene & Tropical Medicine ( LSHTM )Krishnan Bhaskaran - Corresponding Applicant - London School of Hygiene & Tropical Medicine ( LSHTM )Eva Buzasi - Collaborator - London School of Hygiene & Tropical Medicine ( LSHTM )Garth Funston - Collaborator - University of CambridgeHelen Strongman - Collaborator - London School of Hygiene & Tropical Medicine ( LSHTM )Helena Carreira - Collaborator - London School of Hygiene & Tropical Medicine ( LSHTM )Kathryn Mansfield - Collaborator - London School of Hygiene & Tropical Medicine ( LSHTM )

CPRD253

Over the past decades, earlier detection of cancer through screening programmes and better cancer treatments have improved survival for many people with cancer. However, there are concerns that some cancer treatments may have long-term effects on bone health, leading to more broken bones and consequent diminished quality of life, increased risk of death and costs to healthcare services.

Over the past decades, advances in cancer detection and treatment have resulted in improved survival, whilst raising concerns about long-term adverse consequences. It has been suggested that people receiving cancer therapy may experience higher rates of bone loss, osteoporosis and bone fracture. However, there is currently little population-based evidence on this. The relationship between cancer survival and bone health is important to understand considering the high burden of morbidity and mortality associated with fracture and consequent reduced quality of life, in addition to the substantial financial costs to the health service.

23/04/2021

Release